Saroja Pharma Industries India Limited (NSE: SAROJA)
India
· Delayed Price · Currency is INR 58.20
0.00 (0.00%)
At close: Oct 1, 2024
SAROJA Revenue
In the fiscal year ending March 31, 2024, Saroja Pharma Industries India had annual revenue of 406.69M INR, down -18.97%. Saroja Pharma Industries India had revenue of 195.51M in the half year ending March 31, 2024.
Revenue
406.69M
Revenue Growth
-18.97%
P/S Ratio
0.50
Revenue / Employee
n/a
Employees
13
Market Cap
233.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 406.69M | -95.24M | -18.97% |
| Mar 31, 2023 | 501.93M | -54.39M | -9.78% |
| Mar 31, 2022 | 556.33M | 189.71M | 51.75% |
| Mar 31, 2021 | 366.62M | 195.82M | 114.65% |
| Mar 31, 2020 | 170.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries Limited | 9,252.89B |
| Tata Consultancy Services Limited | 2,441.25B |
| HDFC Bank Limited | 2,663.37B |
| Bharti Airtel Limited | 1,510.49B |
| ICICI Bank Limited | 1,686.78B |
| Infosys Limited | 1,555.41B |
| State Bank of India | 3,319.63B |
| Hindustan Unilever Limited | 621.07B |